NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hyundai Pharm (KO: 004310)

 
004310 Technical Analysis
4
As on 17th Jul 2025 004310 STOCK Price closed @ 4400.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 3991.01 & Strong Buy for SHORT-TERM with Stoploss of 3866.82 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

004310STOCK Price

Open 3540.00 Change Price %
High 4560.00 1 Day 890.00 25.36
Low 3480.00 1 Week 925.00 26.62
Close 4400.00 1 Month 905.00 25.89
Volume 30250415 1 Year 390.00 9.73
52 Week High 5820.00 | 52 Week Low 3000.00
 
KO Korea Most Active Stocks
068330 2170.00 15.86%
068330 2170.00 15.86%
152550 383.00 19.69%
152550 383.00 19.69%
008970 1786.00 0.62%
008970 1786.00 0.62%
096300 156.00 -6.02%
096300 156.00 -6.02%
168490 159.00 29.27%
168490 159.00 29.27%
 
KO Korea Top Gainers Stocks
119650 1581.67 244.59%
119650 1581.67 244.59%
000545 10510.00 29.91%
000545 10510.00 29.91%
000545 10510.00 29.91%
168490 159.00 29.27%
168490 159.00 29.27%
004310 4400.00 25.36%
004310 4400.00 25.36%
000100 135800.00 20.50%
 
KO Korea Top Losers Stocks
002210 973.00 -65.00%
002210 973.00 -65.00%
002210 973.00 -65.00%
009275 1800.00 -64.50%
009275 1800.00 -64.50%
010145 6580.00 -60.83%
010145 6580.00 -60.83%
001745 3600.00 -46.27%
001745 3600.00 -46.27%
016385 10450.00 -37.05%
 
 
004310
Daily Charts
004310
Intraday Charts
Whats New @
Bazaartrend
004310
Free Analysis
 
004310 Important Levels Intraday
RESISTANCE6481.16
RESISTANCE5813.72
RESISTANCE5401.16
RESISTANCE4988.60
SUPPORT3811.40
SUPPORT3398.84
SUPPORT2986.28
SUPPORT2318.84
 
004310 Forecast July 2025
4th UP Forecast4901.02
3rd UP Forecast4740.34
2nd UP Forecast4641.02
1st UP Forecast4541.7
1st DOWN Forecast4258.3
2nd DOWN Forecast4158.98
3rd DOWN Forecast4059.66
4th DOWN Forecast3898.98
 
004310 Weekly Forecast
4th UP Forecast4795.04
3rd UP Forecast4668.35
2nd UP Forecast4590.04
1st UP Forecast4511.73
1st DOWN Forecast4288.28
2nd DOWN Forecast4209.97
3rd DOWN Forecast4131.66
4th DOWN Forecast4004.97
 
004310 Forecast2025
4th UP Forecast11385.4
3rd UP Forecast9145.13
2nd UP Forecast7760.38
1st UP Forecast6375.63
1st DOWN Forecast2424.38
2nd DOWN Forecast1039.63
3rd DOWN Forecast-345.13
4th DOWN Forecast-2585.38
 
 
004310 Other Details
Segment EQ
Market Capital 167270400000.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
004310 Address
004310
 
004310 Latest News
 
Your Comments and Response on Hyundai Pharm
 
004310 Business Profile
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antiviral, cardiovascular, central nervous system, contraceptive, depilatory, dermatological, diagnostic, digestive system, endocrine system, ENT, hemostatic, hormone therapy, musculo-skeletal system, ophthalmic, oral disease, respiratory, urogenital system, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial, arthritis, constipation, disinfectant, lip care, nutrition, and wound healing. It also develops products for the treatment of type 2 diabetes, bronchitis, senile disease, and osteoporosis. The company was founded in 1965 and is headquartered in Seoul, South Korea. Address: Hyundai Pharm Building, Seoul, South Korea, 06121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service